Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.

Ma, Chunlong; Wang, Jun

Ma, Chunlong; Wang, Jun.

Ma C; Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721.
Wang J; Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721 junwang@pharmacy.arizona.edu.

Proc Natl Acad Sci U S A ; 118(8)2021 02 23.

Article in English | MEDLINE | ID: covidwho-1387609

Subject(s)

COVID-19 Drug Treatment; Oxytetracycline; Pharmaceutical Preparations; Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; Cyclopropanes; Dipyridamole; Humans; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oxytetracycline / Pharmaceutical Preparations / COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google